Providers & delivery partners
A credible service.
Ready to deliver.
Independent regulatory judgement for CROs, CDMOs, access providers and supply organisations developing a service, strengthening capability or managing change.
Contribute the capability the programme needs.
A sponsor or marketing authorisation holder may want to retain its existing clinical supply and GDP providers, systems and programme oversight. IAE helps assess the proposed access route, supplier suitability and responsibilities, then define specialist contributions for the gaps that remain.
An EDC, ePRO service, access portal, research team or translation provider can support a defined part of the programme. Each needs an agreed scope, appropriate qualification, clear interfaces and acceptance criteria. Existing suppliers are retained where suitable for the product, country, site and activity; continuity is conditional on that assessment.
The sponsor’s decisions, contracts, programme records, reporting access and exit arrangements remain explicit. Define who performs each delegated activity and who accepts it, including safety and quality handovers.
We assess proposed collaborations and system connections case by case. This is a modular delivery model, not an announcement of approved technology partners or operating integrations. IAE provides regulatory and evidence-planning support, not licensed import, GDP distribution or a full-service CRO.
Explore sponsor oversight and supplier continuityAssess evidence collection and technologyA sponsor wants more than your current service.
The opportunity is clear. The responsibilities behind the proposal may be less settled.
A new offer can bring activities, interfaces and expectations that the existing model was not designed to handle. IAE helps test what is being proposed, where specialist capability is needed and what the organisation can responsibly commit to.
A useful result
A defined scope, capability and governance assessment, with boundaries, sponsor interfaces and an implementation sequence.
The delivery model is changing.
A country addition, new warehouse or partner change can move responsibility as well as product.
IAE examines the proposed activity alongside the regulatory basis, quality interfaces, accountable parties and continuity requirements. The assessment connects your part of the pathway with the organisations before and after it.
A useful result
A transition assessment and readiness plan: unresolved questions, required evidence, handovers and the decisions needed before implementation.
Stronger delivery starts with a clear agreement.
IAE can review a proposed scope, help build the operating arrangements or provide continuing senior regulatory input. The assignment can support a provider or its commissioning organisation; the commissioner, boundaries and relevant conflicts are made explicit.
Daniel’s experience connects regulatory leadership with international access programmes and delivery interfaces. Specialist quality, clinical, legal or local input is agreed where needed.
See regulatory governance and oversightMeet Daniel and the approachA clearer view of the next decision.
Bring the opportunity or the sticking point.
Share what you want to deliver, what is changing and where the uncertainty sits. IAE will help define a useful next piece of work.
Discuss your delivery modelScope, responsibilities and fees are agreed before commissioned work begins.
What could we make useful together?
Explore service design, accessible resources, evidence, digital tools and community contributions. Start with your audience and leave with a clearer brief.
Explore ways to work together